Morepen Laboratories Limited -1.2 % Drug Manufacturers - Major

Trend Analysis

Loading...

Support and Resistance Levels Analysis
The current close value 24.6 is between the support and resistance channel of 023 and 026. The stock has a Observe Signal , 023 becomes a critical support to stop the fall and 026 is a immediate resistance on the upside. Note that in case of a Observe Signal, the stocks tends to change trends. This happens mostly near the support and resistance levels.
Technical Indicators (3 Month duration)
Exponential Moving average 23.7
MACD value -1.3
Price range 19.75 to 35.65
Volume range 390077 to 2780908
Support & Resistance 23, 26
Stock Performance
Six Months -31.8%
Five Months-18.0%
Four Months-11.0%
Three Months-15.0%
Two Months-15.9%
One Month-8.2%
Last Six Months

-31.8%

Last Five Months

-18.0%

Last Four Months

-11.0%

Last Three Months

-15.0%

Last Two Months

-15.9%

Last One Month

-8.2%

Analysis
Volume
Today's Price Range
3 Month Price Range
About Morepen Laboratories Limited
Morepen Laboratories Limited is an India-based pharmaceutical company. The Company operates through four segments; they are Active Pharmaceutical Ingredients (API), Domestic Formulations, Diagnostics and Over the Counter (OTC). The API segment has developed new products like Sitagliptin Phosphate, Rosuvastatin Calcium, Olmesartan Medoxomil and Aliskiren in the Research and Development laboratory. The Domestic Formulations segment markets over 100 branded formulations in 8 major therapeutic segments. The Diagnostics segment markets under its own brand name Clinical and Home Health devices and Blood Banking machines. The OTC segment market brands like Burnol ,Lemolate, Sat-Isabgol, Option -72, Head-X, Fever-X , C- Candy and other Over the Counter (OTC) products. The Company has 3 manufacturing facilities, for manufacture of API, formulations and OTC products with international standings.
See stocks similar to Morepen Laboratories Limited in Drug Manufacturers - Major

Morepen Laboratories Limited has Observe Signal. What is your opinion on it?

{ }